找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Hyperhidrosis; A Complete Guide to Marcelo de Paula Loureiro,José Ribas M. de Campos, Book 2018 Springer International Publishing AG, part

[復(fù)制鏈接]
樓主: 不幸的你
11#
發(fā)表于 2025-3-23 12:43:09 | 只看該作者
Psychiatric Features in Hyperhidrosisitation as a form of intermittent dysautonomia. High rates of anxiety are present in primary hyperhidrosis patients. In its turn, high rates of hyperhidrosis are present in patients with anxiety disorders. Therefore, clinicians should be aware of investigating this correlation and possible co-morbidity.
12#
發(fā)表于 2025-3-23 17:31:58 | 只看該作者
Pharmacological Treatment of Hyperhidrosisurrently the first therapeutic line for these patients, allowing the treatment of generalized forms, revolutionizing the treatment of these patients, and indicating surgical treatment only in refractory cases, and thus reducing the number of cases of compensatory hyperhidrosis.
13#
發(fā)表于 2025-3-23 20:27:46 | 只看該作者
Botulinum Toxin for Axillary and Palmar Hyperhidrosiseatments without the necessity of invasive surgical procedures. Although more useful for axillary hyperhidrosis, BTX injections can also be effective in treating palmar and plantar disease. The effects of BTX last for 6–9 months on average, and treatment is associated with a high satisfaction rate among patients.
14#
發(fā)表于 2025-3-24 00:05:21 | 只看該作者
15#
發(fā)表于 2025-3-24 02:47:19 | 只看該作者
Marcelo de Paula Loureiro,José Ribas M. de Campos,Hyperhidrosis affects at least 1% of global population..There is no specialized literature about hyperhidrosis..Clinicians and health professionals in general are uninformed about hyperhidrosis..Speci
16#
發(fā)表于 2025-3-24 06:31:53 | 只看該作者
http://image.papertrans.cn/h/image/430646.jpg
17#
發(fā)表于 2025-3-24 13:13:15 | 只看該作者
18#
發(fā)表于 2025-3-24 17:11:46 | 只看該作者
The Prevalence of Hyperhidrosis WorldwidePrimary hyperhidrosis (PH), excessive sweating, has an unknown origin with onset in childhood or puberty and interferes with quality of life. Thus, it is important to know the prevalence of PH in order to offer a definitive treatment.
19#
發(fā)表于 2025-3-24 22:07:16 | 只看該作者
20#
發(fā)表于 2025-3-25 00:35:57 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 13:34
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
洛扎县| 启东市| 建湖县| 田东县| 恩平市| 夏邑县| 通江县| 云梦县| 金塔县| 吐鲁番市| 梁河县| 定远县| 平塘县| 珲春市| 凤山市| 宜丰县| 蓬安县| 库车县| 积石山| 抚松县| 资溪县| 台安县| 新安县| 江川县| 朝阳区| 滨海县| 商都县| 灌云县| 黄大仙区| 呼玛县| 盱眙县| 金湖县| 河西区| 塘沽区| 达孜县| 三原县| 汉阴县| 同仁县| 洛浦县| 康定县| 陕西省|